Fetalix’s Post

🚀 Kitea Health Partners with SCHOTT for Groundbreaking Miniaturized Brain Implant! 🧠✨ Kitea Health, a pioneering medtech startup from New Zealand, has unveiled the world's first miniaturized brain implant designed for real-time intracranial pressure monitoring. This innovative device aims to revolutionize care for neurological conditions like hydrocephalus, significantly enhancing patient outcomes. Key Highlights: - First Human Implantation: Successfully implanted in June 2024! - Collaboration with SCHOTT: Utilizing Proteon™ all-glass encapsulation technology for unprecedented miniaturization. - Real-Time Monitoring: Seamlessly transmits data to smartphones, reducing emergency visits and improving quality of life. - Clinical Trials Underway: Currently testing with 20 patients and expanding to 150 in 2025. With plans for FDA and CE mark approvals by 2027, Kitea Health is set to make a global impact across Europe, the US, and Asia. 🌍 This partnership marks a significant leap forward in smart medical devices—offering hope to millions of patients worldwide! 👉 Click the link to learn more about this transformative technology! #BrainImplant #Healthcare #Innovation #KiteaHealth #MedTech #Neurology #Partnership #SCHOTT #MarketAccess #MarketAccessToday

At Juniper, we believe that the key to developing and bringing to market our breakthrough #Neuromodulation micro-implant for #PelvicHealth lies in the active involvement of both clinicians and patients themselves. Their expertise and insights are invaluable in shaping a readily adoptable, personalized procedure and therapy. 🩺 Why Clinician Involvement Matters: Expert Insights: Clinicians bring firsthand experience and knowledge, ensuring our technologies effectively address challenges in clinical practice. Patient-Centered Care: Collaboration with healthcare providers helps us design therapies that meet diverse patient needs across specialties. Innovative Solutions: By working closely with clinicians, we are innovating and refining our implant and procedure for better outcomes and usability. Together, we are committed to dramatically improved therapy for patients with pelvic health conditions. ----------------------------------------------------------- #MedicalInnovation #PatientCare #HealthcareCollaboration #MedTech

𝐍𝐞𝐮𝐫𝐨𝐦𝐨𝐝𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐄𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐑𝐞𝐚𝐜𝐡 $𝟏𝟏.𝟎 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟐𝟖 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭 : https://lnkd.in/gFDfvf28 On the basis of type, the internal #neuromodulation market is segmented into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electrical stimulation. The spinal cord stimulation accounted for the largest share of the market in 2022. The increasing number of people suffering from FBSS (failed back surgery syndrome), ischemia, and chronic pain will drive the market growth. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: ANT Neuro Neuromod Devices Neuspera Medical Inc. NEUROBITE Magnus Medical Neuronoff, Inc. CEN - Centro Europeo de Neurociencias CENNEURO Helius Medical Technologies, Inc. Theras Cogentix Medical, Inc. ANEUVO Rev.1 Engineering® - A subsidiary of ASAHI Filmecc. Pixium Vision S.A. WISE S.r.l. CorTec Nyxoah StemoniX Actipulse Neuroscience® Axiom Healthcare Services Feelmore Labs SpineX Inc. Donatelle ShiraTronics, Inc. Alliance Spine and Pain Centers neurocare group Newronika S.p.A. Micro-Leads Medical Sana Health Center for Pain Management ADMEDES Brainclinics Foundation Diagnostic Pain Center of Texas (DPC) Soterix Medical Axonis Therapeutics Johns Hopkins HEPIUS Innovation Lab RxFunction, Inc. Aleva Neurotherapeutics SA Longeviti Neuro Solutions Galvani Bioelectronics Boston Scientific Dorado #neuromodulation #neuromodulationTrends #neuromodulationdemands

2️⃣4️⃣ 𝗠𝗲𝗱𝘁𝗲𝗰𝗵 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗠𝗼𝘃𝗶𝗻𝗴 𝗧𝗵𝗲 𝗡𝗲𝗲𝗱𝗹𝗲 𝗜𝗻 '2️⃣4️⃣ Here are 24 hand-selected companies that MD+DI think you should be tracking in '24... 🥽AppliedVR - #RelieVRx - Immersive platform using #VR to redirect the brain's attention to manage #chronicpain & #anxiety ⚡Argá Medtech SA - #ArgaCSE - #PFA #electroporation ablation technology for treating cardiac arrhythmias including #Afib ❤️🩹Avertix Medical - #Guardian - Subcutaneous implant using #ML to monitor the heart's activity & risk of #heartattack 🧲 BiVACOR, Inc. - #TAH - #Artificialheart using magnetic technology to replace both #ventricles of a failing heart 🦵🏼Bone Health Technologies - #Osteoboost - #Wearable belt device delivering vibration to the #spine & hips to improve bone health 📈Canary Health - #CanaryHealth - Implantable #sensor technology with complementary #data and analytics ecosystem 👴🏻Cognito Therapeutics - #CognitoTX - Disease-modifying #digitalhealth to treat #neurodegenerative diseases inc #Alzheimers 🫀Conformal Medical - #CLAAS - #Transcatheter implant to occlude #LAA to prevent #stroke in patients with non-valvular Afib ♂Contraline - #Adam - Non-hormonal & non-permanent male #contraceptive using injectable #hydrogel 🤖EndoQuest Robotics™ - #EndoLuminal System - An endoluminal #roboticsurgery system to perform #GI surgery less invasively 👶🏼Gabi SmartCare - #GabiBand - Miniaturized #monitoring bracelet for babies which connects to a #digitalplatform 🔌Galvanize Therapeutics, Inc. Therapeutics - #Aliya - #PFA platform for chronic #bronchitis, #cardiacarrhythmia & more 🧑🏾⚕️MIVI Neuroscience, Inc - #QAspirationCatheter - Cather incorporating a pusher wire used in treating #acuteischemicstroke 🌙Moon Surgical - #Maestro - #Robotic system designed to be small, adaptable & easily integrated into #clinicalworkflows 👓Neurolens - #Neurolens - Prescription #lenses specifically for adults with digital vision syndrome (#DVS) 🫁Noah Medical - #Galaxy - A #roboticsurgery system for #bronchoscopy diagnosis & treatment, among other indications 🥼Perfuze - #Superbore - #Aspiration technology with increased tip surface area for use in complex #neurovascular procedures 🦴RefleXion Medical - #Scintix - Biology-guided #radiotherapy system to control delivery to tumors 💧Reprieve Cardiovascular - #Reprieve - Automated #fluidmanagement system for acute decompensated #heartfailure 💻Perspectum Ltd - #Perspectum platform - #AI software imaging solutions to diagnose #chronicdisease & #cancer 👀Rayner - #RaynerIOLs - #IOL and injections for use in #cataract #ophthalmicsurgery 👁️SpyGlass Pharma, Inc. - #SpyGlass - Intraocular #drugdelivery platform for cataract & #glaucoma ❤️🔥Supira Medical - #pVad - Percutaneous #VAD for patients undergoing #interventional procedures 💩Vibrant Gastro - #VibrantSystem - Drug-free vibrating capsule designed to treat #constipation Watch this space... #medicaldevice #medtech #executivesearch

𝐒𝐩𝐨𝐭𝐥𝐢𝐠𝐡𝐭 𝐨𝐧 𝐑𝐨𝐭𝐚𝐭𝐨𝐫 𝐂𝐮𝐟𝐟 𝐈𝐧𝐣𝐮𝐫𝐲 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭: 𝐓𝐫𝐞𝐧𝐝𝐬 & 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐆𝐮𝐢𝐝𝐞: https://lnkd.in/d6i583YR As the global population ages and sports-related injuries rise, the demand for rotator cuff injury treatments is expanding. The market is projected to grow at a significant pace, driven by advancements in surgical techniques, rehabilitation therapies, and non-invasive treatments like regenerative medicine. 🔑 Key Market Drivers: • 🌍 Aging Population: Increased cases of degenerative shoulder conditions are contributing to higher demand. • 🏃♂️ Active Lifestyle Trends: Sports enthusiasts, especially in high-impact activities, are more susceptible to rotator cuff injuries. • 🧬 Innovative Therapies: From biologic solutions like PRP (Platelet-Rich Plasma) and stem cell therapy to cutting-edge arthroscopic surgeries, innovations are transforming recovery and patient outcomes. 🌟 What’s New? • Non-Surgical Options: Physical therapy, anti-inflammatory treatments, and regenerative medicine are gaining popularity. • Surgical Advancements: Minimally invasive techniques and faster recovery times are becoming standard. • Smart Rehabilitation Tools: Wearables and digital health platforms are making recovery more accessible and data-driven. 📈 Market Outlook: According to industry reports, the rotator cuff injury treatment market is expected to see robust growth over the next decade, especially in developed regions, due to the increasing awareness and availability of advanced treatment options. As healthcare professionals and stakeholders, staying updated with these trends is crucial to driving patient success and business growth. 💡 Key Players:  Arthrex Zimmer Biomet FH Ortho Integra LifeSciences Reckitt EVOLUTIS INDIA PVT LTD Johnson & Johnson GSK CONMED Corporation #RotatorCuffInjury #ShoulderInjury #Orthopedics #SportsMedicine #PhysicalTherapy #ShoulderRehab #InjuryRecovery #RotatorCuffSurgery #ShoulderPainRelief #TendonRepair #ShoulderInjuryTreatment #RotatorCuffTear #InjuryPrevention #ShoulderRehabilitation #PRPTherapy #ShoulderInjuryRecovery #StrengthAndConditioning #PostOpRehab #ArthroscopicSurgery #ShoulderMobility

At what point in the history of medicine was the brake of ethics and morality removed from this science? Did anyone in humanity ask for this technological breakthrough? Who are the investors in this? There are so many questions and a long list of why each point of this video explanation should not even be considered. Totally dystopian. #AI #Robotics #Science #Technology #Medical #Brain #innovation #Ethics

Neuromodulation Devices Market Research Report: #Neuromodulation Devices Market Size, Share & Trends Analysis Report By Type (Spinal Cord Stimulation Devices, #DeepBrain Stimulation Devices, Vagus Nerve #Stimulation Devices, Sacral Nerve Stimulation Devices, Gastric Electric Stimulation Devices), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028 The #NeuromodulationDevices Market is driven by several factors that reflect the growing demand for #innovative #treatments for various neurological and chronic conditions. Here are the primary driving factors: 1. Rising Prevalence of Neurological Disorders Chronic Conditions: The increasing incidence of neurological disorders such as Parkinson’s disease, epilepsy, chronic pain, depression, and migraines is a significant driver of the neuromodulation devices market. As the global population ages, the prevalence of these conditions is expected to rise, further boosting demand for these devices. 2. #Technological Advancements in Neuromodulation Innovation: Continuous advancements in technology, including #miniaturization, improved battery life, #wirelesscommunication, and enhanced precision in stimulation, have made neuromodulation devices more effective and patient-friendly. These innovations are expanding the scope of conditions that can be treated with these #devices. 3. Increasing Preference for Minimally Invasive Treatments Patient Demand: There is a growing preference for minimally #invasive #procedures that offer shorter recovery times, reduced pain, and lower risk of complications. Neuromodulation #devices, often implanted through minimally invasive techniques, are becoming an attractive option for patients and healthcare providers alike. 📚𝗚𝗲𝘁 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁𝗮𝘁 𝗗𝗶𝘀𝗰𝗼𝘂𝗻𝘁𝗲𝗱 𝗣𝗿𝗶𝗰𝗲::👇 https://lnkd.in/dBc2HpjH NDI Medical Neucomed Neuravi Neurizon NeuroMedical NeuroMetrix, Inc. Neuromodulation Market Access Neuronetics, Inc. Neuronix. NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) NeuroPace. NeuroSigma. Neurotech International Ltd Nevro Nexeon MedSystems, Inc. Nocturnal Nuvectra Polar Medical Ltd. Prime MedTech ReShape Lifesciences Inc. Rev.1 Engineering® - A subsidiary of ASAHI Filmecc. Saluda Medical Sante International, Inc. SECOND SIGHT MEDICAL PRODUCTS INC SetPoint Medical ShiraTronics, Inc. Soterix Medical. SPR Therapeutics, Inc. St. Jude Medical. Synapse Biomedical. Uroplasty, Inc. is now Cogentix Medical, Inc VYGON YINGCHI

🚀 Samsung Medison has acquired the French AI #medtech startup Sonio for €86 million, marking a significant step in expanding its AI-powered #healthcare solutions. #Sonio specializes in #AI for diagnostic reporting in obstetrics and gynecology ultrasound, with its FDA-approved Sonio Detect solution automating prenatal screening. 🔗 This acquisition is expected to create strong synergies between Sonio's #AItechnology and #Samsung's medical expertise, improving efficiency and helping bridge the global healthcare gap. Sonio will continue to operate independently in #France, maintaining compatibility with all ultrasound device makers. 🌍 #Samsung's strategy is to strengthen its #leadership in cutting-edge #medical devices, with this #collaboration expected to drive a paradigm shift in prenatal ultrasound exams. Source: Tech Funding News #AI #MedTech #HealthcareInnovation #SamsungMedison #Sonio #PrenatalCare #UltrasoundTechnology #MedicalDevices #FutureTechly

Imagine transforming brain therapy without ever needing to drill through the skull! NeuroBionics, an MIT spinout, is set to change the landscape of neurological treatment with their hair-thin bioelectric fibers. These fibers, as small as a human hair, can be guided through blood vessels in the brain to deliver neuromodulation therapy—a groundbreaking alternative to invasive brain surgery. Using carbon nanotubes, these fibers promise higher durability and less tissue damage compared to traditional metal electrodes, making MRI scans much more efficient. Supported by industry investors like Steve Jurvetson, and having just secured $5 million in funding, the potential applications are vast: from treating Parkinson's to delivering drugs directly into the brain. NeuroBionics is on a path to revolutionize how we think of brain therapies, with the first human trials anticipated by 2030. Ready to witness the future of medical technology? Keep an eye on NeuroBionics, as they may hold the key to less invasive, safer, and more effective brain treatments. Source: TechCrunch #NeuroBionics #Biotech #Health #Innovation #MedicalTech #Neurology

Startup BrainBridge Presented Futuristic Head Transplant Technology. Biotechnology company BrainBridge, founded by blogger, screenwriter and biologist Hashem Al-Ghaili, presented the concept of a revolutionary device capable of transplanting a human head onto a donor body. The developers claim that this technology will be a real salvation for patients suffering from incurable diseases such as cancer, paralysis, Alzheimer's and Parkinson's disease. The BrainBridge system will be based on the work of multi-armed robots controlled by artificial intelligence. The robots will accurately remove the head from the patient's body and then transplant it onto the donor's body, connecting the nerve endings, spine and circulatory system. In addition to head transplants, BrainBridge plans to provide cosmetic surgery services, including face and scalp transplants with minimal risk of rejection. Al-Ghaili first mentioned BrainBridge on social networks in 2023. Then he set himself the goal of assembling a team of the best specialists to challenge the modern limitations of medicine. According to his calculations, it will be possible to carry out the first head transplant in 8 years. This is reported by daily.afisha.ru. #linkedin #brainbridge #AI #robotic #cosmetic #surgery #advancedtechnology #futuristic #head #transplant #doctors #medicalstudents #linkedincommunity #surgeons #radiologist #neurologist #imaging #professionals #healthworkers #humanbody #awareness #knowledge #orthopedics #physiotherapist #sportsman #athlete #trainer #linkedinlearning